Conference - Boston, MA, United States
We are excited to announce GTCbio's 13th Vaccines Research & Development: All Things Considered Conference, which will take place July 8-10, 2015 in Boston, MA.
Newly emerging infections have opened up dialogue about the need for novel treatments and government response to these diseases. In the past year, the unprecedented Ebola outbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges.
We invite you to join us as colleagues from industry and academia gather to discuss newly licensed vaccines, new vaccine technologies, and advances in hot topics such as RNA-based vaccines. In addition to scientific presentations and updates on research happening over the past year, colleagues will meet and connect in an accessible environment.
Organization: GTCbio
For more information, please visit: https://www.gtcbio.com/conferences/vaccines-research-development-overview?utm_source=13vax&utm_medium=EventListing&utm_campaign=13vax
July 8, 2015 - July 10, 2015 (08:00 am - 05:00 pm)
Hyatt Regency Boston
Boston, MA 10178, United States
Contact: Kristen Starkey (infogtcbio@gtcbio.com)
Phone: 6262566405
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
